GI360 – Comprehensive Stool Analysis

Beschrijving

GI360 – Comprehensive Stool Analysis (Microbiome, Pathogens & Gut Function)

The GI360™ is a comprehensive stool test designed to provide a complete evaluation of gastrointestinal health, combining advanced molecular diagnostics with traditional microbiology and functional biomarkers.

This panel integrates multiplex PCR, culture-based microbiology, microscopy, and biochemical markers to assess microbiome balance, detect pathogens, evaluate digestion, inflammation, and gut barrier function. It is considered one of the most advanced stool analyses available for clinical use.

Why this is not a basic stool test

Standard stool tests typically assess a limited number of pathogens or a single marker such as calprotectin. In contrast, the GI360™ provides a multi-layered evaluation of the gut ecosystem:

• DNA-based microbiome analysis assessing bacterial diversity and dysbiosis
• Multiplex PCR detection of bacterial, viral, and parasitic pathogens
• Culture-based identification of bacteria and yeast with susceptibility testing
• Microscopic parasitology for comprehensive parasite detection
• Functional markers of digestion, inflammation, and gut environment

This integrated approach provides significantly more clinical insight compared to basic or single-method stool testing. :contentReference[oaicite:0]{index=0}

What this test evaluates

• Microbiome composition, diversity, and Dysbiosis Index
• Bacterial, viral, and parasitic pathogens (PCR)
• Beneficial and dysbiotic bacteria (culture & identification)
• Yeast and fungal overgrowth
• Parasitology via microscopy
• Digestive function (enzymes and absorption markers)
• Inflammation (calprotectin, lactoferrin, immune markers)
• Gut barrier function (e.g. zonulin)
• Microbial metabolites (short-chain fatty acids)

Analytes Included

Clinical Value

The GI360™ provides a comprehensive assessment of the gastrointestinal system, allowing clinicians to identify multiple contributing factors in a single test. It combines microbiome analysis, infection detection, digestive evaluation, and immune markers into one integrated report.

This approach supports more precise diagnosis and targeted treatment strategies, particularly in complex or chronic conditions where multiple factors may be involved.

Who may benefit

• Patients with chronic digestive symptoms (bloating, IBS, constipation, diarrhea)
• Suspected dysbiosis, infections, or microbiome imbalance
• Autoimmune, inflammatory, or skin conditions linked to gut health
• Chronic fatigue, brain fog, or systemic symptoms
• Patients requiring a comprehensive, root-cause gut assessment

Sample Type

Stool samples collected over multiple days using a dedicated collection kit.

Turnaround Time

Approximately 10 to 14 working days after sample arrival at the laboratory.